APA (7th ed.) Citation

Johnson, R. M., Qu, X., Lin, C., Huw, L., Venkatanarayan, A., Sokol, E., . . . Bais, C. (2022). ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer. Nature Communications, 13(1), . https://doi.org/10.1038/s41467-022-33172-5

Chicago Style (17th ed.) Citation

Johnson, Radia M., et al. "ARID1A Mutations Confer Intrinsic and Acquired Resistance to Cetuximab Treatment in Colorectal Cancer." Nature Communications 13, no. 1 (2022). https://doi.org/10.1038/s41467-022-33172-5.

MLA (9th ed.) Citation

Johnson, Radia M., et al. "ARID1A Mutations Confer Intrinsic and Acquired Resistance to Cetuximab Treatment in Colorectal Cancer." Nature Communications, vol. 13, no. 1, 2022, https://doi.org/10.1038/s41467-022-33172-5.